O-GlcNAcylation of connexin 40: A sweet connection between diabetes and endothelial cell dysfunction? Focus on “O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice”

American Journal of Physiology - Cell Physiology

Volumn 309, Issue 9, 2015, Pages C590-C592

  Issad, Tarik ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CONNEXIN 40; DOXYCYCLINE; TETRACYCLINE; BETA N ACETYLHEXOSAMINIDASE; HISTONE ACETYLTRANSFERASE; HYALURONOGLUCOSAMINIDASE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CAPILLARY DENSITY; CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GAP JUNCTION; GENE OVEREXPRESSION; HEART VENTRICLE; HYPERPOLARIZATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; O GLCNACYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; SMOOTH MUSCLE FIBER; ANIMAL; BIOSYNTHESIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HUMAN; MALE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, NEOPLASM; BETA-N-ACETYLHEXOSAMINIDASES; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HISTONE ACETYLTRANSFERASES; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE;

EID: 84946026935     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00260.2015     Document Type: Editorial

References (10)

1. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiol 3: S54-S61, 1998.
2. Feletou M, Vanhoutte PM. EDHF: an update. Clin Sci (Lond) 117: 139-155, 2009.
3. Herve JC, Sarrouilhe D. Modulation of junctional communication by phosphorylation: protein phosphatases, the missing link in the chain. Biol Cell 94: 423-432, 2002.
4. Issad T, Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol Metab 19: 380 - 389, 2008.
5. Issad T, Masson E, Pagesy P. O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab 36: 423-435, 2010.
6. Lima VV, Giachini FR, Carneiro FS, Carneiro ZN, Fortes ZB, Carvalho MH, Webb RC, Tostes RC. Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli. J Am Soc Hypertens 2: 410- 417, 2008.
7. Luo B, Soesanto Y, McClain DA. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol 28: 651-657, 2008.
8. Makino A, Dai A, Han Y, Youssef KD, Wang W, Donthamsetty R, Scott BT, Wang H, Dillmann WH. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice. Am J Physiol Cell Physiol (August 12, 2015). doi:10.1152/ajpcell. 00069.2015.
9. Makino A, Platoshyn O, Suarez J, Yuan JX, Dillmann WH. Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am J Physiol Cell Physiol 295: C221-C230, 2008.
10. Musicki B, Kramer MF, Becker RE, Burnett AL. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 102: 11870-11875, 2005.